Matthew Fust

Matthew Fust serves as a board member for several publicly traded and venture-backed biopharmaceutical companies and is a corporate finance and strategy advisor in the life sciences industry. He was named to NACD’s 2022 Directorship 100. Matthew is an advocate for corporate board diversity, with a focus on LGBTQ+ inclusion, and is senior advisor to Out Leadership’s OutQUORUM corporate board diversity initiative.

Posts